Citadel Advisors - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$9,496,000
-60.2%
11,813,000
-62.2%
0.00%
-72.7%
Q1 2020$23,866,000
-39.6%
31,256,000
-33.2%
0.01%
-35.3%
Q4 2019$39,499,000
+0.3%
46,756,000
-2.1%
0.02%
-10.5%
Q3 2019$39,368,000
+9.7%
47,756,000
+6.7%
0.02%
+18.8%
Q2 2019$35,898,000
+37.3%
44,756,000
+49.2%
0.02%
+23.1%
Q1 2019$26,145,000
+32.8%
30,006,000
+39.6%
0.01%
+18.2%
Q4 2018$19,691,000
+151.4%
21,500,000
+186.7%
0.01%
+266.7%
Q3 2018$7,834,000
+51.8%
7,500,000
+50.0%
0.00%0.0%
Q2 2018$5,160,000
-59.0%
5,000,000
-59.0%
0.00%
-57.1%
Q1 2018$12,586,000
-15.2%
12,200,000
-29.1%
0.01%
-22.2%
Q4 2017$14,844,000
-52.4%
17,200,000
-46.2%
0.01%
-62.5%
Q3 2017$31,163,000
-0.4%
32,000,000
-1.5%
0.02%
-11.1%
Q2 2017$31,295,00032,500,0000.03%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 1,500,000$1,492,0002.87%
Telemetry Investments, L.L.C. 8,000,000$7,780,0002.78%
Context Capital Management, LLC 3,500,000$3,405,0002.28%
Kamunting Street Capital Management, L.P. 2,500,000$2,431,0001.54%
BASSO CAPITAL MANAGEMENT, L.P. 12,205,000$11,824,0001.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 17,500,000$17,269,0001.34%
CAMDEN ASSET MANAGEMENT L P /CA 32,375,000$31,485,0001.04%
Jabre Capital Partners S.A. 5,500,000$5,328,0001.04%
City Financial Investment Co Ltd 12,500,000$12,168,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,250,000$15,747,0000.71%
View complete list of AMAG PHARMACEUTICALS INC shareholders